health
Allogeneic CAR T Therapy Shows MRD Clearance in Large B-Cell Lymphoma
Interim data from the phase 2 ALPHA3 trial show cema-cel achieved 58.3% MRD clearance and 97.7% ctDNA reduction in MRD-positive LBCL patients vs a 26.6% increase in the observation arm.
MED confidence
Coverage (0 articles)
No articles in this topic yet.